M&A Deal Summary

Inari Medical Acquires LimFlow

On November 1, 2023, Inari Medical acquired medical products company LimFlow for 250M USD

Acquisition Highlights
  • This is Inari Medical’s 1st transaction in the Medical Products sector.
  • This is Inari Medical’s largest (disclosed) transaction.
  • This is Inari Medical’s 1st transaction in France.

M&A Deal Summary
Date 2023-11-01
Target LimFlow
Sector Medical Products
Buyer(s) Inari Medical
Deal Type Add-on Acquisition
Deal Value 250M USD

Target

LimFlow

Paris, France
LimFlow is a medical device company, transforming the treatment of CLTI, a severe condition, for which there is a growing clinical need in light of high mortality rates. LimFlow is based in Paris, France.

Search 199,847 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Inari Medical

Irvine, California, United States
Category Company
Founded 2011
Sector Medical Products
Employees1,300
Revenue 494M USD (2023)
DESCRIPTION

Inari Medical is a medical device company dedicated to the development of innovative catheter-based technologies for the treatment of venous thromboembolism. Inari is focused on solutions that enable the safe removal of large clot volumes from big vessels without the use of thrombolytic drugs. Inari has developed two novel mechanical thrombectomy technology platforms. The FlowTriever System has FDA clearance for the treatment of pulmonary embolism and for thrombectomy in the peripheral vessels. The ClotTriever System has FDA clearance for thrombectomy in the peripheral vessels. Inari was founded in 2011 and is based in Irvine, California.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (France) 1 of 1
Year (2023) 1 of 1
Size (of disclosed) 1 of 1
Mergr

Product

Company

Legal